Advanced search
Publication Cover
Cancer Investigation Volume 26, 2008 - Issue 3
Submit an article Journal homepage
409
Views
38
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLECellular and Molecular Biology

OSM, LIF, Its Receptors, and Its Relationship with the Malignance in Human Breast Carcinoma (In Situ and in Infiltrative)

Ignacio García-Tuñón Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain
,
Monica Ricote Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain
,
Antonio Ruiz Department of Pathology, Hospital Príncipe de Asturias, E-28871, Alcalá de Henares, Madrid, Spain
,
Benito Fraile Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain
,
Ricardo Paniagua Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain
&
Mar Royuela Department of Cell Biology and Genetics, University of Alcalá, Alcalá de Henares, Madrid, Spain
Pages 222-229 | Published online: 11 Jun 2009

REFERENCES

  • Heinrich P. C., Behrmann I., Haan S., Hermanns H. M., Müller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003; 374: 1–20
  • Hibi M., Nakajima K., Hirano T. IL-6 cytokine family and signal transduction: a model of the cytokine system. J. Mol. Med. 1996; 74: 1–12
  • Gearing D. P., Comeau M. R., Friend D. J. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1434–1437
  • Peters M., Muller A. M., Rose-John S. Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis. Blood 1998; 92: 3495–3504
  • Heinrich P. C., Behrmann I., Müller-Newen G., Schaper F., Graeve L. IL-6-type cytokine signalling through the gp130/JAK/STAT pathway. Biochem. J. 1998; 334: 297–314
  • Horn D., Fitzpatrick W. C., Gompper P. T., Ochs V., Bolton-Hanson M., Zarling J. M., Malik N., Todaro G. J., Linsley P. S. Regulation of cell growth by recombinant oncostatin M. Growth Factors 1990; 2: 157–165
  • Douglas A. M., Grant S. L., Goss G. A., Clouston D. R., Sutherland R. L., Begley C. G., Oncostatin M. induces the differentiation of breast cancer cells. Int. J. Cancer 1998; 75: 64–73
  • Liu J., Hadjokas N., Mosley B., Estrov Z., Spence M. J., Vestal R. E. Oncostatin m specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells. Cytokine 1998; 10: 295–302
  • Kellokumpu-Lehtinen P., Talpaz M., Harris D., Van Q., Kurzrock R., Estrov Z. Leukemia-inhibitory factor stimulates breast, kidney and prostate cancer cell proliferation by paracrine and autocrine pathways. Int. J. Cancer 1996; 66: 515–519
  • Estrov Z., Samal B., Lapushin R., Kellokumpu-Lehtinen P., Sahin A. A., Kurzrock R., Talpaz M., Aggarwal B. B. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J Interferon Cytokine Res. 1995; 15: 905–913
  • Douglas A. M., Goss G. A., Sutherland R. L., Hilton D. J., Berndt M. C., Nicola N. A., Begley C. G. Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 1997; 14: 661–669
  • Grant S. L., Douglas A. M., Goss G. A., Begley C. G. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells. Growth Factors 2001; 19: 153–162
  • Dhingra K., Sahin A., Emami K., Hortobagyi G. N., Estrov Z. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Res. Treat 1998; 48: 165–174
  • Garcia-Tuñon I., Ricote M., Ruiz A., Fraile B., Paniagua R., Royuela M. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Histopathology 2005; 47: 82–89
  • UICC. TNM Classification of malignant tumor. International Union against Cancer, GenevaSwitzerland 1968
  • Mylonas I., Makovitzky J., Shabani N., Richter D. U., Kuhn C., Jeschke U., Briese V., Friese K. Leukaemia inhibitory factor (LIF) is immunohistochemically expressed in normal, hyperplastic and malignant endometrial tissue. Eur. J. Obstet. Gynecol. Reprod. Biol. 2005; 118: 101–108
  • Chung T. D., Yu J. J., Spiotto M. T., Bartkowski M., Simons J. W. Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 1999; 38: 199–207
  • Royuela M., Ricote M., Parsons M. S., Garcia-Tuñón I., Paniagua R., De Miguel M. P. Imunohistochemical analysis of IL-6 family of cytokines and their receptors in bening hyperplastic and malignan human prostate. J. Pathol. 2004; 202: 41–49
  • McKenzie R. C., Szepietowski J. Cutaneous leukemia inhibitory factor and its potential role in the development of skin tumors. Dermatol. Surg. 2004; 30: 279–290
  • Turkson J., Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000; 19: 6613–6626
  • Catlet-Falcone R., Landowski T., Oshiro M., Turkson J., Levitski A., Savino R., Ciliberto G., Moscinski L., Fernandez-Luna J., Nuñez G., Dalton W., Jove R. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999; 10: 105–115
  • Bromberg J., Wrzeskczynska M., Devgan G., Zhao Y., Pestell R., Albanese C., Darnell J., Jr. Stat3 as an oncogene. Cell 1999; 8: 295–303
  • Ni Z., Lou W., Leman E., Gao A. Inhibition of contitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells. Cancer Res. 2000; 59: 5059–5063

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.